BFC Planning’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.34K Hold
8,000
– – ﹤0.01% 2651
2026
Q2
$5.6K Hold
8,000
– – ﹤0.01% 2633
2026
Q1
$13K Hold
8,000
– – ﹤0.01% 1915
2025
Q4
$14.2K Hold
8,000
– – ﹤0.01% 1903
2025
Q3
$19.3K Hold
8,000
– – ﹤0.01% 1597
2025
Q2
$18.2K Hold
8,000
– – ﹤0.01% 1536
2025
Q1
$21.5K Buy
8,000
+4,000
+100% +$11.3K ﹤0.01% 1426
2024
Q4
$10.5K Buy
4,000
+2,000
+100% +$5.38K ﹤0.01% 1744
2024
Q3
$5.36K Buy
+2,000
New +$5.46K ﹤0.01% 1986

Other funds holding NSPR

BFC Planning's NSPR Position: Q3 2026 in Review

BFC Planning held its InspireMD (NSPR) position steady in Q3 2026 at 8,000 shares worth $5.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

BFC Planning first reported a position in NSPR in Q3 2024 and has held it in 9 quarters since. The position peaked at $21.5K in Q1 2025. 27 funds tracked by Wall St. Rank hold NSPR as of Q3 2026.

  • BFC Planning held 8,000 shares of InspireMD worth $5.34K as of Q3 2026.
  • BFC Planning left its InspireMD share count unchanged in Q3 2026.
  • InspireMD made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2651 holding.
  • BFC Planning first reported a position in InspireMD in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's InspireMD position peaked at $21.5K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held InspireMD as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.